DISTRIBUTION AGREEMENTDistribution Agreement • October 2nd, 2015 • Zaxis International Inc • Blank checks
This Distribution Agreement (the "Agreement") is effective per 1 December 2013 BETWEEN: EMERALD MEDICAL APPLICATIONS LTD. (the "Company"), a corporation organized and existing under the laws of the State of Israel with its head office located at: 7,Yoshfe Street, Modiin, 7174636, ISRAEL AND: S.Bokhorst - Creatiekracht (the "Distributor"), a corporation organized and existing under the laws of the Netherlands, with its head office located at: Specht 21, 3766WN Soest, Netherlands RECITALS WHEREAS, Company has developed DermaCompare, Software as a Service (SaaS) platform described in Schedule A attached here (the "Products") and desires to grant Distributor the right to market and distribute the Products; and WHEREAS, Distributor is in the business of marketing and distributing medical products and desires to have Developer grant to it the right to market and distribute the Products. NOW, THEREFORE, in consideration of the mutual promises set forth herein, the partie
PROJECT AGREEMENTProject Agreement • October 2nd, 2015 • Zaxis International Inc • Blank checks
This Project Agreement is made on this 14 day of January, 2015, and entered into by and between Realize S.A, ., established at Marousi, 2 Kapodistriou Str. with VAT GR-099604146, Ubitech GIOUMPITEK MELETI SCHEDIASMOS YLOPOIISI KAI POLISI ERGON PLIROFORIKIS ETAIREIA PERIORISMENIS EFTHYNIS, established in Athens, 36-38 Mithridatou Str. with VAT GR-998908360, MEDISP, Medical Signal and Image Processing Lab, Technological Educational Institute of Athens, Ag. Spyridonos Street, Egaleo 12210, Athens Greece, Number: 090077522, MPUoP Medical Physics Laboratory, University of Patras, Greece, Rio 26504, Greece, Number: 998219694, and Emerald Medical Applications Ltd., a limited liability company with company number 514410307, incorporated and existing under the laws of the State of Israel, and having its principal offices at 1 Emek Ayalon St., Modi'in, Israel ("Emerald"). Each of the parties hereto may also be referred to as "Party" and jointly as "Parties").
DISTRIBUTION AGREEMENTDistribution Agreement • October 2nd, 2015 • Zaxis International Inc • Blank checks
This Distribution Agreement (the "Agreement") is effective 08/12/2013 BETWEEN: EMERALD MEDICAL APPLICATIONS LTD. (the "Company"), a corporation organized and existing under the laws of the State of Israel with its head office located at: 7, Yoshfe Street Modiin 7174636, ISRAEL AND: DERMA ITALY Srl (the "Distributor"), a corporation organized and existing under the laws of the Italy, with its head office located at: Via Amsterdam 75 - 00144 Rome - Italy RECITALS WHEREAS, Company has developed DermaCompare, Software as a Service (SaaS) platform described in Schedule A attached here (the "Products") and desires to grant Distributor the right to market and distribute the Products; and WHEREAS, Distributor is in the business of marketing and distributing medical products and desires to have Developer grant to it the right to market and distribute the Products. NOW, THEREFORE, in consideration of the mutual promises set forth herein, the parties hereto agree as follo
DISTRIBUTION AGREEMENTDistribution Agreement • October 2nd, 2015 • Zaxis International Inc • Blank checks
This Distribution Agreement (the "Agreement”) is effective 6th FEBRUARY 2014. BETWEEN: EMERALD MEDICAL APPLICATIONS LTD. (the “Company”), a corporation organized and existing under the laws of the State of Israel with its head office located at: 7, Yoshfe Street, Modiin 7174636, ISRAEL AND: Medical Edge Pty Ltd (the "Distributor"), a corporation organized and existing under the laws of the Victoria, Australia with its head office located at: P.O Box 2331 Caulfield Junction VICTORIA AUSTRALIA 3162 RECITALS WHEREAS, Company has developed DermaCompare, Software as a Service (SaaS) platform described in Schedule A attached here (the "Products") and desires to grant Distributor the right to market and distribute the Products; and WHEREAS, Distributor is in the business of marketing and distributing medical products and desires to have Developer grant to it the right to market and distribute the Products. NOW, THEREFORE, in consideration of the mutual promises set for
